论文部分内容阅读
紫杉醇(又称紫素),是一种具有复杂二萜类化学结构的新抗肿瘤药,对转移性乳腺癌、非小细胞肺癌、晚期卵巢癌具有明显的治疗效果,临床应用日益广泛,为肿瘤化疗增加了一种新制剂。而紫杉醇注射液化疗的护理、输液和配制有别于其它化疗药物。现将我们在治疗中的护理体会报告如下。一、材料与方法(一)一般资料1995年6月～1999年12月,以紫杉醇注射液治疗恶性肿瘤32例,其中乳腺癌14例、非小细胞肺癌12例、卵巢癌6例。年龄范围32～69岁,平均年龄43岁。女22例,男10例。静脉注射紫杉醇注射液共79次,发生骨髓抑制28例(87.5%),过敏反应6次
Paclitaxel (also known as purple), is a new anti-tumor drug with complex diterpenoid chemical structure, and has obvious therapeutic effect on metastatic breast cancer, non-small cell lung cancer and advanced ovarian cancer. The clinical application is as follows: Tumor chemotherapy adds a new formulation. The paclitaxel injection chemotherapy care, infusion and preparation is different from other chemotherapy drugs. Now we are in the treatment of nursing experience as follows. First, the material and methods (A) of the general information June 1995 ~ December 1999, paclitaxel injection treatment of 32 cases of malignant tumors, including 14 cases of breast cancer, non-small cell lung cancer in 12 cases, 6 cases of ovarian cancer. The age range of 32 to 69 years old, average age 43 years old. Female 22 cases, 10 males. Intravenous injection of paclitaxel a total of 79 times, bone marrow suppression occurred in 28 cases (87.5%), anaphylactic reaction 6 times